Homburger advised private equity fund ArchiMed on the acquisition of Stragen Pharma

On June 24, 2021, private equity healthcare fund ArchiMed announced the acquisition of Stragen Pharma from its founder and several shareholders. Based near Geneva, Switzerland and founded in 1990, Stragen is a developer of hard-to-make, complex generic drugs for the treatment of patients with life-threatening conditions that require comprehensive care and monitoring, usually in intensive care units. Stragen sales of some EUR 70 m in 2020 are growing at a double-digit annual pace. Stragen’s 40 different products are sold in over 60 countries around the world, with a strong European focus.

Homburger acted as Swiss legal counsel to ArchiMed. The Homburger team was led by partner Frank Gerhard, and comprised lead associate Sarah Chevalley, associate Léonard Aeschlimann Perales and junior associate Alessandra Dumitru (all Corporate / M&A), as well as counsel Peter Müller (Tax).